Treatment of chronic fatigue syndrome and fibromyalgia syndrome

Details Treatment of chronic fatigue syndrome and fibromyalgia syndrome Treatment of chronic fatigue syndrome and fibromyalgia syndrome

2001-10-31

2009-06-30

Hui, San-ming (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

C514S171000, C514S182000

Reexamination Certificate

active

07553829

ABSTRACT:
Chronic fatigue syndrome (CFS) and fibromyalgia syndrome (FMS) can be treated by the administration of Δ5-androstene-3β-ol-7,17 dione and metabolizable precursors thereof.

REFERENCES:
patent: 5206008 (1993-04-01), Loria
patent: 5292730 (1994-03-01), Lardy
patent: 5296481 (1994-03-01), Partridge et al.
patent: 5461042 (1995-10-01), Loria
patent: 5585371 (1996-12-01), Lardy
patent: 5641766 (1997-06-01), Lardy
patent: 5641768 (1997-06-01), Loria
patent: 5707983 (1998-01-01), Lardy
patent: 5885977 (1999-03-01), Pauza et al.
patent: 5900420 (1999-05-01), Cole
patent: 5919460 (1999-07-01), Ingram
patent: 5935949 (1999-08-01), White
patent: 5990162 (1999-11-01), Scharf
patent: 6372732 (2002-04-01), Lardy et al.
patent: 6489313 (2002-12-01), Lardy et al.
patent: 873699 (1953-04-01), None
patent: 45-37770 (1966-03-01), None
patent: WO99/25192 (1999-05-01), None
Lahita RG., Collagen disease: the enemy within. Int. J. Fertile Women's Med. Sep.-Oct 1998; 43(5):229-34.
Kizildere S., During a corticotropin-releasing hormone test in healthy subjects administration of a beta-adrenergic antagonist induced secretion of cortisol and dehydroepiandrosterone sulfate and inhibited secretion of ACTH, Eur. J Endocrinol. 2003;148(1):45-53.
Scott LV., Differences in adrenal steroid profile in chronic fatigue syndrome, in depression and in health. Journal of Affective Disorders, 1999 ; 54(1-2):129-37.
De Becker P. Dehydroepiandrosterone (DHEA) Response to i.v. SCTH in Patients with Chronic Fatigue Syndrom, Horm Metab Res 1999; 31:18-21.
Kuratsune H., Dehydroepiandrosterone sulfate deficiency in chronic fatigue syndrome, International Journal of Molecular Medicine, 1998:143-146.
Nelson R., Dehydroepiandrosterone and 7-Keto DHEA Augment Interleukin 2(IL-2) Production by Human Lymphocytes in Vitro, Feb. 1998 Chicago, IL.

Affiliated with

Also associated with

Rating

Treatment of chronic fatigue syndrome and fibromyalgia syndrome does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of chronic fatigue syndrome and fibromyalgia syndrome, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of chronic fatigue syndrome and fibromyalgia syndrome will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4081036